Drug intelligence / Profile preview

Ultralife

Development stage
Unknown
Lead developer
Grevis Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

**Ultralife** is an over-the-counter ophthalmic lubricant developed and manufactured by **Grevis Pharma** (Grevis Pharmaceuticals). It is formulated as eye drops containing a combination of **polyethylene glycol** (0.4%) and **propylene glycol** (0.3%). The product is primarily indicated for the temporary relief of burning, irritation, and discomfort associated with dry eye syndrome, environmental factors (such as wind, smoke, or air conditioning), and digital eye strain. Mechanistically, the active ingredients function as humectants and lubricants that mimic natural tears, coating the ocular surface to reduce moisture evaporation and facilitate smooth movement of the eyelids over the cornea.

Brand names
Ultralife
Other names
polyethylene glycol 400 + propylene glycolpolyethylene glycol and propylene glycolpolyethylene glycol, propylene glycol

Beyond the preview

Go deeper on Ultralife.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultralife.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call